Pushing the Frontiers: Optogenetics for Illuminating the Neural Pathophysiology of Bipolar Disorder
- PMID: 37781027
- PMCID: PMC10535711
- DOI: 10.7150/ijbs.84923
Pushing the Frontiers: Optogenetics for Illuminating the Neural Pathophysiology of Bipolar Disorder
Abstract
Bipolar disorder (BD), a disabling mental disorder, is featured by the oscillation between episodes of depression and mania, along with disturbance in the biological rhythms. It is on an urgent demand to identify the intricate mechanisms of BD pathophysiology. Based on the continuous progression of neural science techniques, the dysfunction of circuits in the central nervous system was currently thought to be tightly associated with BD development. Yet, challenge exists since it depends on techniques that can manipulate spatiotemporal dynamics of neuron activity. Notably, the emergence of optogenetics has empowered researchers with precise timing and local manipulation, providing a possible approach for deciphering the pathological underpinnings of mental disorders. Although the application of optogenetics in BD research remains preliminary due to the scarcity of valid animal models, this technique will advance the psychiatric research at neural circuit level. In this review, we summarized the crucial aberrant brain activity and function pertaining to emotion and rhythm abnormities, thereby elucidating the underlying neural substrates of BD, and highlighted the importance of optogenetics in the pursuit of BD research.
Keywords: Bipolar disorder; animal model; biological rhythms; frontal-limbic system; optogenetics; pathophysiology.
© The author(s).
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures


Similar articles
-
Cognitive deficits in bipolar disorders: Implications for emotion.Clin Psychol Rev. 2018 Feb;59:126-136. doi: 10.1016/j.cpr.2017.11.006. Epub 2017 Nov 21. Clin Psychol Rev. 2018. PMID: 29195773 Free PMC article. Review.
-
Biological rhythms in bipolar and depressive disorders: A community study with drug-naïve young adults.J Affect Disord. 2015 Nov 1;186:145-8. doi: 10.1016/j.jad.2015.07.004. Epub 2015 Jul 21. J Affect Disord. 2015. PMID: 26241662
-
Timing matters: using optogenetics to chronically manipulate neural circuitry and rhythms.Front Behav Neurosci. 2014 Feb 14;8:41. doi: 10.3389/fnbeh.2014.00041. eCollection 2014. Front Behav Neurosci. 2014. PMID: 24592222 Free PMC article. Review.
-
Optogenetics: What it has uncovered in potential pathways of depression.Pharmacol Res. 2020 Feb;152:104596. doi: 10.1016/j.phrs.2019.104596. Epub 2019 Dec 12. Pharmacol Res. 2020. PMID: 31838082 Review.
-
Pharmacological Manipulation of the Circadian Clock: A Possible Approach to the Management of Bipolar Disorder.CNS Drugs. 2019 Oct;33(10):981-999. doi: 10.1007/s40263-019-00673-9. CNS Drugs. 2019. PMID: 31625128 Review.
Cited by
-
Application of Optogenetic Neuromodulation in Regulating Depression.Curr Med Sci. 2025 Apr;45(2):185-193. doi: 10.1007/s11596-025-00037-z. Epub 2025 Mar 27. Curr Med Sci. 2025. PMID: 40146525 Review.
-
The Breathomics Profile of Volatile Sulfur Compounds in the Bipolar Spectrum, Does It Represent a Potential Tool for Early Diagnosis?J Clin Med. 2025 Mar 17;14(6):2025. doi: 10.3390/jcm14062025. J Clin Med. 2025. PMID: 40142833 Free PMC article.
References
-
- Tursini K, Le Cam S, Schwan R, Gross G, Angioi-Duprez K, Conart JB. et al. Visual electrophysiology and neuropsychology in bipolar disorders: A review on current state and perspectives. Neurosci Biobehav Rev. 2022;140:104764. - PubMed
-
- Anderson IM, Haddad PM, Scott J. Bipolar disorder. BMJ. 2012;345:e8508. - PubMed
-
- Fornaro M, Anastasia A, Monaco F, Novello S, Fusco A, Iasevoli F. et al. Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants. J Affect Disord. 2018;234:131–8. - PubMed
-
- De Berardis D, Vellante F, Pettorruso M, Lucidi L, Tambelli A, Di Muzio I. et al. Suicide and Genetic Biomarkers: Toward Personalized Tailored-treatment with Lithium and Clozapine. Curr Pharm Des. 2021;27:3293–304. - PubMed